BUPIVACAINE — all Canadian products
4 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is BUPIVACAINE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02525968 | ZYNRELEF | HERON THERAPEUTICS, INC. | Solution (Extended-Release) | Instillation | BUPIVACAINE 60 MG; MELOXICAM 1.8 MG | Cancelled Pre Market | |
| 02526018 | ZYNRELEF | HERON THERAPEUTICS, INC. | Solution (Extended-Release) | Instillation | BUPIVACAINE 200 MG; MELOXICAM 6 MG | Cancelled Pre Market | |
| 02526026 | ZYNRELEF | HERON THERAPEUTICS, INC. | Solution (Extended-Release) | Instillation | BUPIVACAINE 300 MG; MELOXICAM 9 MG | Cancelled Pre Market | |
| 02526034 | ZYNRELEF | HERON THERAPEUTICS, INC. | Solution (Extended-Release) | Instillation | BUPIVACAINE 400 MG; MELOXICAM 12 MG | Cancelled Pre Market |
Browse other molecules: